Differding Consulting

Differding Consulting s.p.r.l. was established in 2010 to offer strategic advice on drug discovery activities to pharmaceutical companies, biotech companies and research institutes.

We focus on two areas:

  • Outsourcing and partnering drug discovery activities
  • Drug discovery consultancy

Differding Consulting s.p.r.l. is based in Louvain-la-Neuve (Belgium), South of Brussels, and is building on an expanding global network with contract research organizations, in particular in Asia, and a special focus on India.


 

LATEST NEWS

20.08.15 | DRUG DISCOVERY AND DEVELOPMENT ALLIANCES IN INDIA – UPDATE ON RECENT OUT-LICENSING DEALS

Global pharmaceutical companies including Hoffmann-La Roche, Boehringer Ingelheim, or Pierre Fabre have recently signed major licensing deals with Indian biotech companies to acquire the rights to preclinical development candidates. Cancer is the leading therapeutic indication covered by these deals, with approaches ranging from immuno-oncology to epigenetics, and covering both small molecules and peptides.

READ MORE

26.02.14 | AUNP-12 - A NOVEL PEPTIDE THERAPEUTIC TARGETING PD-1 IMMUNE CHECKPOINT PATHWAY FOR CANCER IMMUNOTHERAPY – STRUCTURE ACTIVITY RELATIONSHIPS & PEPTIDE / PEPTIDOMIMETIC ANALOGS

Aurigene Discovery Technologies, the Bangalore-based biotech company, and Pierre Fabre, the second largest independent French pharmaceutical company, announced on February 11, 2014, a collaborative license, development and commercialization agreement giving Pierre Fabre worldwide rights (excluding India) to a new immune checkpoint modulator, AUNP-12, for the treatment of cancer.

READ MORE